Enter your login e-mail to the account
Search
- Current scientific knowledge about NAFLD/MAFLD during the COVID-19 pandemic and the benefits of essential phospholipids in the treatment of hepatic steatosis
doc. MUDr. Peter Minárik, PhD., MSc, prof. PharmDr. Ján Kyselovič, CSc., prof. MUDr. Ivan Schréter, CSc., doc. MUDr. Zuzana Paraličová, PhD., prof. MUDr. Peter Jarčuška, PhD.
(4/2022, Review articles ) - Triple therapy with protease inhibitors – new standard of care in chronic hepatitis C treatment
doc. MUDr. Pavol Kristian, PhD., prof. MUDr. Ivan Schréter, CSc., doc. MUDr. Peter Jarčuška, PhD.
(6/2011, Review articles ) - Hypolipidemic treatment of patients with nonalcoholic fatty liver disease
doc. MUDr. Peter Jarčuška, PhD., MUDr. Martin Janičko, MUDr. Eduard Veseliny, MUDr. Ján Fedačko, MUDr. Božena Nováková, prof. MUDr. Daniel Pella, CSc.
(6/2010, Topic of the year ) - Poškodenie pečene alkoholom a liekmi
doc. MUDr. Peter Jarčuška, PhD., MUDr. Mária Zakuciová, MUDr. Eduard Veseliny
(10/2006, clearly )
- Rapidly progressive acute liver failure in relapsed multiple myeloma – a case report
MUDr. Tomáš Guman, PhD., MBA, MUDr. Milena Surová, prof. MUDr. Peter Jarčuška, PhD., doc. MUDr. Sylvia Dražilová PhD., MUDr. Peter Bohuš
(6/2024, Main topic ) - Hepatitis B in the cancer patients treated by chemotherapy
MUDr. Tomáš Šálek, doc. MUDr. Peter Jarčuška, PhD., MUDr. Sylvia Dražilová, MUDr. Marian Oltman, MUDr. Ľubomír Skladaný
(6/2011, Review articles )